0001209191-23-041358.txt : 20230705 0001209191-23-041358.hdr.sgml : 20230705 20230705202339 ACCESSION NUMBER: 0001209191-23-041358 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230705 FILED AS OF DATE: 20230705 DATE AS OF CHANGE: 20230705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mohan Raju CENTRAL INDEX KEY: 0001878125 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40928 FILM NUMBER: 231071686 MAIL ADDRESS: STREET 1: C/O VENTYX BIOSCINECES, INC. STREET 2: 332 ENCINITAS BLVD., SUITE 200 CITY: ENCINITAS STATE: CA ZIP: 92024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ventyx Biosciences, Inc. CENTRAL INDEX KEY: 0001851194 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 832996852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 662 ENCINITAS BLVD., STE. 250 CITY: ENCINITAS STATE: CA ZIP: 92024 BUSINESS PHONE: (858) 945-2393 MAIL ADDRESS: STREET 1: 662 ENCINITAS BLVD., STE. 250 CITY: ENCINITAS STATE: CA ZIP: 92024 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-07-05 0 0001851194 Ventyx Biosciences, Inc. VTYX 0001878125 Mohan Raju C/O VENTYX BIOSCIENCES, INC. 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-07-05 4 M 0 29785 8.04 A 1542911 D Common Stock 2023-07-05 4 S 0 17298 37.7438 D 1525613 D Common Stock 2023-07-05 4 S 0 6659 38.7798 D 1518954 D Common Stock 2023-07-05 4 S 0 5920 39.7199 D 1513034 D Common Stock 2023-07-05 4 S 0 123 40.315 D 1512911 D Stock Option (Right to Buy) 8.04 2023-07-05 4 M 0 29785 0.00 D 2031-09-18 Common Stock 29785 425286 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2022. Represents the weighted average share price of an aggregate total of 17,298 shares sold in the price range of $37.26 to $38.1912. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average share price of an aggregate total of 6,659 shares sold in the price range of $38.27 to $39.2592. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average share price of an aggregate total of 5,920 shares sold in the price range of $39.2712 to $40.2624. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average share price of an aggregate total of 123 shares sold in the price range of $40.2723 to $40.3625. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Option granted under pursuant to the Issuer's 2019 Equity Incentive Plan, as amended (the "2019 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined 2019 Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the options shall vest on the one year anniversary of the Vesting Commencement date, and, thereafter, one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean September 17, 2021. /s/ Christopher Krueger, as Attorney-in-Fact 2023-07-05